Malte Peters's most recent trade in Hookipa Pharma Inc was a trade of 29,176 Common Stock done at an average price of $0.9 . Disclosure was reported to the exchange on July 22, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Hookipa Pharma Inc | Malte Peters | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.92 per share. | 22 Jul 2025 | 29,176 | 79,519 (0%) | 0% | 0.9 | 26,842 | Common Stock |
| Tango Therapeutics Inc | Malte Peters | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 37,500 | 37,500 | - | - | Stock Option (Right to Buy) | |
| Tango Therapeutics Inc | Malte Peters | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 6,250 | 17,500 | - | 0 | Common Stock | |
| Hookipa Pharma Inc | Malte Peters | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2024 | 108,695 | 108,695 (0%) | 0% | 0 | Common Stock | |
| Hookipa Pharma Inc | Malte Peters | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2024 | 49,000 | 49,000 | - | - | Stock Option (Right to Buy) | |
| Tango Therapeutics Inc | Malte Peters | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 37,500 | 37,500 | - | - | Stock Option (Right to Buy) | |
| Tango Therapeutics Inc | Malte Peters | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 6,250 | 11,250 | - | 0 | Common Stock | |
| Hookipa Pharma Inc | Malte Peters | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 52,000 | 52,000 | - | - | Stock Option (Right to Buy) | |
| Tango Therapeutics Inc | Malte Peters | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Tango Therapeutics Inc | Malte Peters | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 5,000 | 5,000 | - | 0 | Common Stock | |
| Tango Therapeutics Inc | Malte Peters | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) |